JP2015511587A - アンドロスタン−３β，５α，６β−トリオールの結晶形化合物及びその製造方法 - Google Patents
アンドロスタン−３β，５α，６β−トリオールの結晶形化合物及びその製造方法 Download PDFInfo
- Publication number
- JP2015511587A JP2015511587A JP2014560211A JP2014560211A JP2015511587A JP 2015511587 A JP2015511587 A JP 2015511587A JP 2014560211 A JP2014560211 A JP 2014560211A JP 2014560211 A JP2014560211 A JP 2014560211A JP 2015511587 A JP2015511587 A JP 2015511587A
- Authority
- JP
- Japan
- Prior art keywords
- degrees
- androstane
- triol
- solvent
- crystalline compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title abstract description 5
- 239000013078 crystal Substances 0.000 claims abstract description 146
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 239000002904 solvent Substances 0.000 claims description 58
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 44
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 30
- 238000010790 dilution Methods 0.000 claims description 23
- 239000012895 dilution Substances 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 19
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 15
- 230000007704 transition Effects 0.000 claims description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000004090 dissolution Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 239000003208 petroleum Substances 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract description 22
- 238000002360 preparation method Methods 0.000 abstract description 17
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract description 2
- 230000008018 melting Effects 0.000 abstract description 2
- 238000004467 single crystal X-ray diffraction Methods 0.000 description 27
- 238000000113 differential scanning calorimetry Methods 0.000 description 24
- 238000010586 diagram Methods 0.000 description 13
- 238000005259 measurement Methods 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000004455 differential thermal analysis Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000000547 structure data Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000020938 metabolic status Nutrition 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0007—Androstane derivatives not substituted in position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210060611.6 | 2012-03-08 | ||
| CN201210060611.6A CN102617685B (zh) | 2012-03-08 | 2012-03-08 | 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法 |
| PCT/CN2012/073854 WO2013131305A1 (zh) | 2012-03-08 | 2012-04-11 | 雄甾-3β,5α,6β-三醇的晶型化合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2015511587A true JP2015511587A (ja) | 2015-04-20 |
Family
ID=46557937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014560211A Pending JP2015511587A (ja) | 2012-03-08 | 2012-04-11 | アンドロスタン−３β，５α，６β−トリオールの結晶形化合物及びその製造方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9688716B2 (enExample) |
| EP (2) | EP2889303A4 (enExample) |
| JP (1) | JP2015511587A (enExample) |
| KR (1) | KR20150002653A (enExample) |
| CN (4) | CN103626817B (enExample) |
| AU (1) | AU2012372640B2 (enExample) |
| CA (2) | CA2866398C (enExample) |
| IL (1) | IL234492A (enExample) |
| IN (1) | IN2014DN08198A (enExample) |
| RU (1) | RU2608894C2 (enExample) |
| SG (1) | SG11201405376TA (enExample) |
| TW (1) | TW201336861A (enExample) |
| WO (1) | WO2013131305A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015517418A (ja) * | 2012-05-07 | 2015-06-22 | ザ プロクター アンド ギャンブルカンパニー | 可撓性容器のための可撓性材料 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109985048B (zh) * | 2017-12-29 | 2021-06-29 | 广州市赛普特医药科技股份有限公司 | 2β,3α,5α-三羟基雄甾-6-酮用于炎症反应的治疗 |
| US11532903B2 (en) * | 2021-04-01 | 2022-12-20 | Ideal Industries, Inc. | Universal electrical connector |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961311A (zh) * | 2010-09-21 | 2011-02-02 | 中山大学 | 一种5α-雄甾(烷)-3β,5,6β-三醇注射剂及其制备方法 |
| WO2012003802A1 (zh) * | 2010-07-09 | 2012-01-12 | 中山大学 | 5α-雄甾（烷）-3β，5，6β-三醇在制备神经元保护药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2191576A (en) * | 1936-11-21 | 1940-02-27 | Soc Of Chemical Ind | 3,5,6-trihydroxy androstane and pregnane compounds |
| US2191578A (en) | 1939-07-24 | 1940-02-27 | Crosley Corp | Ice-cream tray |
| ATE15206T1 (de) * | 1981-09-21 | 1985-09-15 | Schering Ag | 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung. |
| US6046185A (en) * | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
| CN102180928B (zh) * | 2011-03-15 | 2013-01-16 | 广州市赛普特医药科技有限公司 | 3β,5α,6β-三羟基甾体化合物及其合成方法和应用 |
-
2012
- 2012-03-08 CN CN201310392426.1A patent/CN103626817B/zh active Active
- 2012-03-08 CN CN201310393026.2A patent/CN103626818B/zh active Active
- 2012-03-08 CN CN201210060611.6A patent/CN102617685B/zh active Active
- 2012-03-08 CN CN201310393373.5A patent/CN103626819B/zh active Active
- 2012-04-11 CA CA2866398A patent/CA2866398C/en active Active
- 2012-04-11 IN IN8198DEN2014 patent/IN2014DN08198A/en unknown
- 2012-04-11 US US14/383,405 patent/US9688716B2/en active Active
- 2012-04-11 RU RU2014136891A patent/RU2608894C2/ru active
- 2012-04-11 JP JP2014560211A patent/JP2015511587A/ja active Pending
- 2012-04-11 WO PCT/CN2012/073854 patent/WO2013131305A1/zh not_active Ceased
- 2012-04-11 SG SG11201405376TA patent/SG11201405376TA/en unknown
- 2012-04-11 CA CA2909998A patent/CA2909998A1/en not_active Abandoned
- 2012-04-11 AU AU2012372640A patent/AU2012372640B2/en active Active
- 2012-04-11 EP EP12870566.2A patent/EP2889303A4/en not_active Withdrawn
- 2012-04-11 KR KR1020147028362A patent/KR20150002653A/ko not_active Ceased
- 2012-04-11 EP EP16184231.5A patent/EP3112374A1/en not_active Ceased
-
2013
- 2013-03-07 TW TW102108093A patent/TW201336861A/zh unknown
-
2014
- 2014-09-07 IL IL234492A patent/IL234492A/en active IP Right Grant
-
2017
- 2017-05-08 US US15/589,228 patent/US9944672B2/en active Active
- 2017-05-08 US US15/589,268 patent/US9944673B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012003802A1 (zh) * | 2010-07-09 | 2012-01-12 | 中山大学 | 5α-雄甾（烷）-3β，5，6β-三醇在制备神经元保护药物中的应用 |
| CN101961311A (zh) * | 2010-09-21 | 2011-02-02 | 中山大学 | 一种5α-雄甾(烷)-3β,5,6β-三醇注射剂及其制备方法 |
Non-Patent Citations (5)
| Title |
|---|
| JPN6015045000; ＧＡＺＥＴＴＡ ＣＨＩＭＩＣＡ ＩＴＡＬＩＡＮＡ ９２, 1962, ７３０-７３７ * |
| JPN6015045001; Ｓｔｅｒｏｉｄｓ ６（６）, 1965, ６９９-７０５ * |
| JPN6015045004; Ｊｏｕｒｎａｌ ｏｆ ｔｈｅ Ｃｈｅｍｉｃａｌ Ｓｏｃｉｅｔｙ． Ｐｅｒｋｉｎ Ｔｒａｎｓａｃｔｉｏｎｓ Ｉ １６, 1972, ２０５１-２０５４ * |
| JPN6015045005; Ｔｅｔｒａｈｅｄｒｏｎ ３０, 1974, ３２７-３３５ * |
| JPN6015045007; Ｃｈｅｍｉｃａｌ ＆ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｂｕｌｌｅｔｉｎ ２９（１）, 1980, ４３-５０ * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015517418A (ja) * | 2012-05-07 | 2015-06-22 | ザ プロクター アンド ギャンブルカンパニー | 可撓性容器のための可撓性材料 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3112374A1 (en) | 2017-01-04 |
| US9688716B2 (en) | 2017-06-27 |
| CN102617685B (zh) | 2014-01-22 |
| CA2866398A1 (en) | 2013-09-12 |
| EP2889303A1 (en) | 2015-07-01 |
| RU2014136891A (ru) | 2016-05-10 |
| AU2012372640A1 (en) | 2014-09-25 |
| US20150045566A1 (en) | 2015-02-12 |
| RU2608894C2 (ru) | 2017-01-26 |
| IN2014DN08198A (enExample) | 2015-05-01 |
| US9944672B2 (en) | 2018-04-17 |
| US20170305958A1 (en) | 2017-10-26 |
| CA2909998A1 (en) | 2013-09-12 |
| CN103626818B (zh) | 2016-03-30 |
| KR20150002653A (ko) | 2015-01-07 |
| CA2866398C (en) | 2016-06-28 |
| US20170305957A1 (en) | 2017-10-26 |
| CN103626819B (zh) | 2016-01-20 |
| CN103626817A (zh) | 2014-03-12 |
| WO2013131305A1 (zh) | 2013-09-12 |
| CN103626817B (zh) | 2016-01-20 |
| CN102617685A (zh) | 2012-08-01 |
| AU2012372640B2 (en) | 2015-07-09 |
| SG11201405376TA (en) | 2014-11-27 |
| IL234492A (en) | 2017-02-28 |
| CN103626818A (zh) | 2014-03-12 |
| US9944673B2 (en) | 2018-04-17 |
| TW201336861A (zh) | 2013-09-16 |
| EP2889303A4 (en) | 2016-02-17 |
| CN103626819A (zh) | 2014-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108373451B (zh) | 一种5-氟尿嘧啶与脯氨酸的共晶及其制备方法 | |
| CN102659822B (zh) | 含有混合配体的混价铜(i/ii)配合物及其制备方法与应用 | |
| CN110922403A (zh) | 阿哌沙班与羧酸形成的共晶及其制备方法 | |
| CN103087111B (zh) | 四唑基钴(ii)配合物磁性材料及其制备方法与应用 | |
| JP2015511587A (ja) | アンドロスタン−３β，５α，６β−トリオールの結晶形化合物及びその製造方法 | |
| Fomina et al. | Influence of the nature of organic components in dinuclear copper (II) pivalates on the composition of thermal decomposition products | |
| CN107522655B (zh) | 一种异烟肼、吡嗪酰胺与富马酸的三元共晶及其制备方法 | |
| CN102746276B (zh) | 一种艾普拉唑钠晶型及其制备方法 | |
| WO2025066367A1 (zh) | 一种共晶的制备方法 | |
| CN102746277B (zh) | 一种结晶形式的艾普拉唑钠及其制备方法 | |
| CN111777552B (zh) | 一种瑞戈非尼与庚二酸的共晶及其制备方法 | |
| CA3076557A1 (en) | Crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and method for preparing same | |
| CN106699652A (zh) | 一种索拉非尼α‑氨基丁酸盐及其制备方法 | |
| CN104926842B (zh) | 一种多铁性化合物及其制备方法 | |
| Wang et al. | Seven New Irbesartan Salts: Significantly Improved Dissolution, Excellent Hygrothermal Stability, and Characteristic Supramolecular Synthons. | |
| WO2025098338A1 (zh) | 一种结晶型化合物或其碱式盐及其制备方法和应用 | |
| WO2024179451A1 (zh) | 一种炔基取代的喹唑啉化合物的晶型、其制备方法和应用 | |
| CN111777551B (zh) | 一种瑞戈非尼与辛二酸的共晶及其制备方法 | |
| Xu et al. | Hydrogen-Bond reorganization of a solid-state dehydration process in a salt of tris (hydroxymethyl) aminomethane and sulfosalicylic acid, investigated by powder x-ray diffraction | |
| CN107365315B (zh) | 一种吡唑类化合物、其晶型及其制备方法 | |
| CN104370942A (zh) | 头孢美唑晶型及其制备方法及一种含有头孢美唑的药物组合物 | |
| CN108440449A (zh) | 一种氢氯噻嗪与脯氨酸的共晶及其制备方法 | |
| CN105712979A (zh) | 一种苹果酸舒尼替尼晶型ⅰ的制备方法 | |
| CN102757353A (zh) | 有机无机杂化室温金属性分子磁体及其制备方法 | |
| CN102675183A (zh) | 一种药物中间体的大规模制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151110 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160205 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20161004 |